| Juan Carlos Rivera-concepcion, MD | |
|
Carr 14 Interior Km 0.3, Centro Medico Menonita, Edificio Profesional Suite 311, Cayey, PR 00736 | |
| (787) 738-9938 | |
| (787) 738-9939 |
| Full Name | Juan Carlos Rivera-concepcion |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | Carr 14 Interior Km 0.3, Cayey, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902800709 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 13838 (Puerto Rico) | Primary |
| Entity Name | Advanced Ob-gyn Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144316803 PECOS PAC ID: 1951537885 Enrollment ID: O20131122000941 |
News Archive
Oncolytics Biotech Inc. today announced initial positive top line data from the first endpoint in its double-blinded randomized Phase III clinical study examining REOLYSIN in combination with carboplatin and paclitaxel in second-line patients with platinum-refractory, taxane-naïve head and neck cancers (REO 018).
Models of human disease are beneficial for medical research, but have limitations in predicting the way a drug will behave within the human body using data from non-human models because of inherent differences between species.
GlaxoSmithKline has announced today that it has extended its previously announced tender offer to purchase all of the outstanding shares of common stock of Genelabs Technologies, Inc. for $1.30 in cash per share without interest and less any required withholding taxes, until 12:00 midnight EST on Friday, December 12, 2008, unless the tender offer is further extended.
Many of us have been wondering whether it's possible to have an honest, reasonable debate about Obamacare. To my pleasant surprise, one may finally be starting.
Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juan Carlos Rivera-concepcion, MD Po Box 1775, Cidra, PR 00739-1775 Ph: (787) 738-9938 | Juan Carlos Rivera-concepcion, MD Carr 14 Interior Km 0.3, Centro Medico Menonita, Edificio Profesional Suite 311, Cayey, PR 00736 Ph: (787) 738-9938 |
News Archive
Oncolytics Biotech Inc. today announced initial positive top line data from the first endpoint in its double-blinded randomized Phase III clinical study examining REOLYSIN in combination with carboplatin and paclitaxel in second-line patients with platinum-refractory, taxane-naïve head and neck cancers (REO 018).
Models of human disease are beneficial for medical research, but have limitations in predicting the way a drug will behave within the human body using data from non-human models because of inherent differences between species.
GlaxoSmithKline has announced today that it has extended its previously announced tender offer to purchase all of the outstanding shares of common stock of Genelabs Technologies, Inc. for $1.30 in cash per share without interest and less any required withholding taxes, until 12:00 midnight EST on Friday, December 12, 2008, unless the tender offer is further extended.
Many of us have been wondering whether it's possible to have an honest, reasonable debate about Obamacare. To my pleasant surprise, one may finally be starting.
Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.
› Verified 1 days ago
Mr. Floren E Perez, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Edificio Oficinas Medicas Menonita, Suite 210, Cayey, PR 00736 Phone: 787-263-1001 Fax: 787-263-7978 | |
Angel D. Nazario-rodriguez, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Carr 14 Interior Km 0.3, Centro Medico Menonita Edificio Profesional Suite 311, Cayey, PR 00736 Phone: 787-738-9938 Fax: 787-738-9939 | |
Dr. James George Wagner, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 8000 Ave. J.t. Pinero, Plaza Cayey, Of. 204, Cayey, PR 00736 Phone: 787-627-2788 Fax: 787-653-2370 | |
Dr. Edgar Israel Rodriguez Rivera, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 52 Calle Salvador Brau, Cayey, PR 00736 Phone: 787-372-1262 | |
Mr. Ivan Guzman-ortiz Sr., MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Edif Prof Hospital Menonita, Suite 210, Cayey, PR 00736 Phone: 787-263-1001 Fax: 787-263-7978 | |
Edward A. Gomez-torres, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Carr 14 Interior Km 0.3, Centro Medico Menonita Edificio Profesional Suite 311, Cayey, PR 00736 Phone: 787-738-9938 Fax: 787-738-9939 | |
Andrea Camarena Sainz, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7 Ave Baldorioty E, Cayey, PR 00736 Phone: 787-738-6444 |